[Beta-receptor blockader LB 46 in the therapy of tachycardial arrhythmias].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004417:Dyspnea / Q000139:chemically induced; D004562:Electrocardiography; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012131:Respiratory Insufficiency / Q000139:chemically induced; D013546:Sweating; D013565:Sympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy*
D000605:Amino Alcohols; D007211:Indoles; D013565:Sympatholytics
Der Beta-Rezeptorenblocker LB 46 in der Therapie von Tachyarrhythmien.